BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17075124)

  • 1. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.
    Griffith OL; Melck A; Jones SJ; Wiseman SM
    J Clin Oncol; 2006 Nov; 24(31):5043-51. PubMed ID: 17075124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers.
    Chan SK; Griffith OL; Tai IT; Jones SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):543-52. PubMed ID: 18349271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker panel diagnosis of thyroid cancer: a critical review.
    Griffith OL; Chiu CG; Gown AM; Jones SJ; Wiseman SM
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1399-413. PubMed ID: 18759692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the clinical application of thyroid cancer biomarkers.
    Shibru D; Chung KW; Kebebew E
    Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
    Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
    Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunohistochemical biomarkers for papillary thyroid carcinoma using gene expression profiling.
    Murphy KM; Chen F; Clark DP
    Hum Pathol; 2008 Mar; 39(3):420-6. PubMed ID: 18261626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
    Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
    Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
    Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
    Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide studies in thyroid neoplasia.
    Giordano TJ
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):311-31, vii-viii. PubMed ID: 18502329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-class predictor based on a probabilistic model: application to gene expression profiling-based diagnosis of thyroid tumors.
    Yukinawa N; Oba S; Kato K; Taniguchi K; Iwao-Koizumi K; Tamaki Y; Noguchi S; Ishii S
    BMC Genomics; 2006 Jul; 7():190. PubMed ID: 16872506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma.
    Rodrigo JP; Rinaldo A; Devaney KO; Shaha AR; Ferlito A
    Head Neck; 2006 Nov; 28(11):1032-9. PubMed ID: 16732600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular tumor markers in thyroid cancer].
    Kopczyńska E; Kwapisz J; Junik R; Tyrakowski T
    Pol Merkur Lekarski; 2007 Apr; 22(130):295-9. PubMed ID: 17684930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECM1 expression in thyroid tumors--a comparison of real-time RT-PCR and IHC.
    Lal G; Padmanabha L; Nicholson R; Smith BJ; Zhang L; Howe JR; Robinson RA; O'Dorisio MS
    J Surg Res; 2008 Sep; 149(1):62-8. PubMed ID: 18374945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.